Yokogawa Electric Corporation has unveiled the new CQ3000, a high-content analysis system for capturing high-definition 3D microscopic images of live cell cultures. Expanding the company’s CellVoyager family of products, the CQ3000 will be launched commercially later in 2024.
The CQ3000 has been designed to capture 3D microscopic images of live cell cultures in high definition at high speed. When used together with Yokogawa’s CellPathfinder image analysis software, the CQ3000 can quantify and analyse intracellular organelles to assess cellular reactions and the effects of drug compounds. It enables highly efficient evaluation of cells in a wide range of applications, from basic research to drug discovery screening.
Hiroshi Nakao, Vice President and head of the Life Business Headquarters at Yokogawa Electric, commented: “The CQ3000 is an enhancement to the CellVoyager series lineup that will accelerate the development of new drugs and streamline basic research in cutting-edge biology and medicine. Through the provision of products and solutions that contribute to drug discovery research and the advancement of individualised medicine and regenerative medicine, Yokogawa’s aims to ensure well-being and quality of life for all.”
The CQ3000 enables the stable and precise observation of live cell cultures over long time periods thanks to Yokogawa's high-precision temperature control and dual spinning-disk with microlens that captures optical slice images (confocal images) with higher speed and better sensitivity, which minimises damage to cells.
By using Yokogawa’s proprietary water immersion lens mechanism, in addition to detailed observation at high magnification levels, it is also possible to capture bright images at low magnification levels. The use of an optional uniformiser achieves even illumination across the entire field of view, for the capture of vivid images.
